Different hypertension thresholds and cognitive decline: a pooled analysis of three ageing cohorts

Yanjun Ma1,2,3, Rong Hua1,2, Zhenchun Yang4

  • 1Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China.

BMC Medicine
|November 2, 2021
PubMed

Insights

Individuals with borderline blood pressure (BP) between 130/80 and 140/90 mmHg did not show increased cognitive decline. This suggests that antihypertension therapy may not be necessary for this group, considering cognitive health.

Area of Science:

  • Gerontology
  • Cardiology
  • Neurology

Background:

  • Conflicting definitions of hypertension exist: 2017 ACC/AHA guidelines define it as ≥130/80 mmHg, while 2018 ESC/ESH guidelines use ≥140/90 mmHg.
  • This discrepancy impacts clinical decisions regarding blood pressure management.

Purpose of the Study:

  • To compare cognitive decline trajectories in adults based on differing blood pressure (BP) thresholds.
  • To investigate the impact of borderline BP (130/80-140/90 mmHg) on cognitive function compared to normal BP (<130/80 mmHg).

Main Methods:

  • Pooled analysis of three large, nationally representative cohorts: Health and Retirement Study (HRS), English Longitudinal Study of Ageing (ELSA), and China Health Retirement Longitudinal Study (CHARLS).
  • Participants were categorized into Normal (BP <130/80 mmHg), Borderline (BP <140/90 mmHg but not Normal), and High BP groups.
  • Global cognitive function was assessed using memory, executive function, and orientation tests, with a global cognitive Z-score calculated.

Main Results:

  • No significant difference in the rate of global cognitive decline was observed between the Normal and Borderline BP groups for both men and women.
  • Participants in the High BP group exhibited a significantly faster rate of cognitive decline compared to the Borderline BP group.
  • The study included 17,590 participants with median follow-up periods ranging from 7 to 16 years.

Conclusions:

  • Borderline blood pressure levels (130/80-140/90 mmHg) are not associated with a significantly faster rate of cognitive decline compared to normal levels.
  • Initiating antihypertension therapy for individuals with borderline BP may not be necessary solely based on concerns about cognitive decline.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
27
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
102
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
26
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
170
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
371
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.5K